Literature DB >> 14034788

[Immunological studies in blood diseases].

E KORINTH.   

Abstract

Entities:  

Keywords:  ANTIBODIES; HEMATOLOGY

Mesh：

Substances：

Year:  1963        PMID： 14034788     DOI： 10.1007/BF01631182

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


× No keyword cloud information.
  9 in total

1.  [Localization of blood group antibodies (isoantibodies) with agglutination electrophoresis].

Authors:  G BERG; F SCHEIFFARTH
Journal:  Acta Haematol       Date:  1956-04       Impact factor: 2.195

2.  [Physiology and chemistry of substances active on blood groups].

Authors:  G F SPRINGER
Journal:  Schweiz Med Wochenschr       Date:  1957-04-07

3.  [Insufficiency in formation of agglutinins in a plasmocytoma].

Authors:  E KORINTH
Journal:  Blut       Date:  1957-07

4.  [Requests of internists to radiologists].

Authors:  E HAFTER; A WERNLI-HASSIG
Journal:  Schweiz Med Wochenschr       Date:  1958-01-04

5.  The behavior in the Coombs test of anti-A and anti-B produced by immunization with various blood group A and B substances and by heterospecific pregnancy.

Authors:  F C MCDUFFIE; E A KABAT
Journal:  J Immunol       Date:  1956-07       Impact factor: 5.422

6.  Heterogeneity of antibodies to the human blood groups in normal and immune sera.

Authors:  R D OWEN
Journal:  J Immunol       Date:  1954-07       Impact factor: 5.422

7.  [Binding ability of red blood corpuscles for isoagglutinins in individual phases of life].

Authors:  H LODENKAMPER; G STIENEN
Journal:  Arztl Wochensch       Date:  1953-01-30

8.  Experimental determination of the hypersensitive diathesis in man.

Authors:  W P CREGER; S H CHOY; L A RANTZ
Journal:  J Immunol       Date:  1951-04       Impact factor: 5.422

9.  Immuno-chemical studies on blood groups; the preparation of blood group A and B substances and an inactive substance from individual horse stomachs and of blood group B substance from human saliva.

Authors:  H BAER; E A KABAT; V KNAUB
Journal:  J Exp Med       Date:  1950-01-01       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.